Title

Oral contraceptives and skin cancer: is there a link?

Document Type

Article

Peer Reviewed

1

Publication Date

1-1-2005

Journal/Book/Conference Title

American journal of clinical dermatology

Volume

6

NLM Title Abbreviation

Am J Clin Dermatol

PubMed ID

16343023

Abstract

The skin expresses estrogen, progesterone, and androgen receptors. In the presence of steroid hormones, such as those contained in oral contraceptives, the skin likely responds to hormonal signals that control the cell cycle, apoptosis, DNA replication, and other cellular functions. Some estrogen-responsive pathways have the potential to promote tumor development, including the augmentation of epidermal growth factor signaling, the expression of proto-oncogenes, and inhibition of apoptosis. The question of whether oral contraceptives increase the risk for the development of skin cancer, particularly melanoma, is still an area of concern. This paper reviews the available evidence, the bulk of which suggests that while the skin responds to estrogens, progestins, and androgens, these responses do not significantly increase the risk of developing skin cancer when estrogen exposure is not excessive.

Keywords

Animals, Cell Cycle, Contraceptives, Oral, Hormonal/pharmacology, Gonadal Steroid Hormones/pharmacology, Humans, Melanoma/epidemiology/metabolism, Receptors, Steroid/metabolism, Skin/drug effects, Skin Neoplasms/epidemiology/metabolism



This document is currently not available here.

Share

COinS
 

URL

http://ir.uiowa.edu/obgyn_pubs/36